NCT07343466

Brief Summary

The project "Investigating Quality of Life and the Influence of Stress on the Postoperative Course of Patients After Device Implantation" aims to investigate the relationship between stress and the postoperative healing process of patients who have had a medical device implanted. These devices include pacemakers for the treatment of bradycardia, implantable cardioverter-defibrillators (ICDs) for the treatment of tachycardia in primary and secondary prevention, and cardiac resynchronization therapy (CRT) devices and event recorders. The study will analyze the influence of stress on the postoperative course, potential complications, and overall quality of life. A combination of medical examinations and surveys will be used to analyze how psychological stress influences the physical healing process and which measures can contribute to improving quality of life and treatment success. The surgical procedure for implanting devices is not part of the study; this is an observational study.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
39mo left

Started Feb 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Feb 2025Jul 2029

Study Start

First participant enrolled

February 4, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 15, 2025

Completed
5 months until next milestone

First Posted

Study publicly available on registry

January 15, 2026

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2029

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2029

Last Updated

January 15, 2026

Status Verified

June 1, 2025

Enrollment Period

4.4 years

First QC Date

August 15, 2025

Last Update Submit

January 6, 2026

Conditions

Keywords

Impact of Stresspostoperative courseICDCRTPacemakerEvent-RecorderprospektiveQuality of life

Outcome Measures

Primary Outcomes (1)

  • Cumulative incidence of device-related complications

    Measures the incidence of device-related complications, this includes: Complications related to Device- pockets, leads and infections connected to the devices

    36 Months

Secondary Outcomes (16)

  • hospitalisation rate

    36 Months

  • Number of participants with the following arrhythmic events: ventrikular tachykardia and ventrikular fibrillation

    Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months

  • Changes in functional capacity

    Baseline (at 4-6 weeks) , after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months

  • combined global stress measure

    Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months

  • Health-related quality of life - SF-36

    Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months

  • +11 more secondary outcomes

Study Arms (1)

Patients with indication for device implantation (pacemaker, ICD, CRT, event recorder)

Patients with cardiac diseases, that makes a device implantation (pacemaker, ICD, CRT, event recorder) necessary, including primary and secondary indication for an ICD.

Other: Survey using a questionnaire.

Interventions

survery over 36 months with comparison of the questionnares with risk-factors, blood-samples and physical fitness of the patient

Patients with indication for device implantation (pacemaker, ICD, CRT, event recorder)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with an indication for device implantation (pacemaker, ICD, CRT, event recorder) who present at the Department of Cardiology and Angiology at the University Hospital Essen

You may qualify if:

  • Patients of legal capacity with an indication for device implantation (pacemaker, ICD, CRT, event recorder) who present at the Department of Cardiology and Angiology at the University Hospital Essen and consent to participate in the study will be included.

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitätsklinikum Essen, Klinik für Kardiologie und Angiologie

Essen, North Rhine-Westphalia, 45147, Germany

RECRUITING

Related Publications (10)

  • Golbidi S, Frisbee JC, Laher I. Chronic stress impacts the cardiovascular system: animal models and clinical outcomes. Am J Physiol Heart Circ Physiol. 2015 Jun 15;308(12):H1476-98. doi: 10.1152/ajpheart.00859.2014. Epub 2015 Apr 17.

    PMID: 25888514BACKGROUND
  • Pedersen SS, Wehberg S, Nielsen JC, Riahi S, Larroude C, Philbert BT, Johansen JB; DEFIB-WOMEN Investigators. Patients with an implantable cardioverter defibrillator at risk of poorer psychological health during 24 months of follow-up (results from the Danish national DEFIB-WOMEN study). Gen Hosp Psychiatry. 2023 Jan-Feb;80:54-61. doi: 10.1016/j.genhosppsych.2022.12.006. Epub 2023 Jan 3.

    PMID: 36638700BACKGROUND
  • Kim J, Park JK, Choi J, Kim SH, On YK, Shin MS, Choi N, Heo S. Changes in the Physical Function and Psychological Distress from Pre-Implant to 1, 6, and 12 Months Post-Implant in Patients Undergoing Implantable Cardioverter Defibrillator Therapy. J Clin Med. 2020 Jan 22;9(2):307. doi: 10.3390/jcm9020307.

    PMID: 31979074BACKGROUND
  • van Barreveld M, Verstraelen TE, van Dessel PFHM, Boersma LVA, Delnoy PPHM, Tuinenburg AE, Theuns DAMJ, van der Voort PH, Kimman GJ, Buskens E, Zwinderman AH, Wilde AAM, Dijkgraaf MGW; DO-IT Registry Investigators. Dutch Outcome in Implantable Cardioverter-Defibrillator Therapy: Implantable Cardioverter-Defibrillator-Related Complications in a Contemporary Primary Prevention Cohort. J Am Heart Assoc. 2021 Apr 6;10(7):e018063. doi: 10.1161/JAHA.120.018063. Epub 2021 Mar 31.

    PMID: 33787324BACKGROUND
  • Miller JL, Thylen I, Elayi SC, Etaee F, Fleming S, Czarapata MM, Lennie TA, Moser DK. Multi-morbidity burden, psychological distress, and quality of life in implantable cardioverter defibrillator recipients: Results from a nationwide study. J Psychosom Res. 2019 May;120:39-45. doi: 10.1016/j.jpsychores.2019.03.006. Epub 2019 Mar 5.

    PMID: 30929706BACKGROUND
  • Lampert R. Managing with pacemakers and implantable cardioverter defibrillators. Circulation. 2013 Oct 1;128(14):1576-85. doi: 10.1161/CIRCULATIONAHA.113.001555. No abstract available.

    PMID: 24081953BACKGROUND
  • Linde C. Quality-of-life in pacemaker and implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol. 2000 Jun;23(6):931-3. doi: 10.1111/j.1540-8159.2000.tb00876.x. No abstract available.

    PMID: 10879374BACKGROUND
  • Su SF, Wu MS. Arrhythmia Perception and Quality of Life in Bradyarrhythmia Patients Following Permanent Pacemaker Implantation. Clin Nurs Res. 2021 Feb;30(2):183-192. doi: 10.1177/1054773819880297. Epub 2019 Oct 16.

    PMID: 31617405BACKGROUND
  • Sikora K, Wawryniuk A, Luczyk RJ, Sawicka K, Zwolak A. The Occurrence of Stress, Illness Acceptance and the Quality of Life of Patients after Pacemaker Implantation. Int J Environ Res Public Health. 2022 Oct 29;19(21):14133. doi: 10.3390/ijerph192114133.

    PMID: 36361008BACKGROUND
  • Iliou MC, Blanchard JC, Lamar-Tanguy A, Cristofini P, Ledru F. Cardiac rehabilitation in patients with pacemakers and implantable cardioverter defibrillators. Monaldi Arch Chest Dis. 2016 Oct 14;86(1-2):756. doi: 10.4081/monaldi.2016.756.

    PMID: 27748467BACKGROUND

Study Officials

  • Tienush Rassaf, Univ.-Prof. Dr. med.

    Universitätsklinikum Essen

    STUDY CHAIR
  • Julia Lortz, Prof. Dr. med.

    Universitätsklinikum Essen

    STUDY DIRECTOR
  • Muhammed Kurt, Dr. med.

    Universitätsklinikum Essen

    STUDY DIRECTOR

Central Study Contacts

Muhammed Kurt, Dr. med.

CONTACT

Julia Lortz, Prof. Dr. med.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 15, 2025

First Posted

January 15, 2026

Study Start

February 4, 2025

Primary Completion (Estimated)

June 15, 2029

Study Completion (Estimated)

July 15, 2029

Last Updated

January 15, 2026

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

All collected data will be stored in pseudonymized form and retained for 10 years after completion or termination of the study, after which it will be destroyed. All study documents, including the pseudonymized list, will be stored and managed on the clinic's own servers. Access to data storage and management will be restricted to authorized personnel (study management, relevant study physicians, and medical doctoral students). Data will not be shared with third parties.

Locations